INS and Insulin resistance: A feature of T2DM is a variable loss of peripheral insulin sensitivity (IS) (8,9); in humans predominantly reflecting reduced efficacy of insulin signaling (‘insulin resistance’, IR) in skeletal muscle and liver (10,11).